Boehringer Ingelheim has launched HatchPak IB H120TM NeO, a freeze-dried live attenuated virus of Bronchitis disease, H120 strain, for active immunisation of one day-old chickens in order to reduce infection with Massachusetts serotype of Infectious Bronchitis virus.

The company says that the effervescent tablet presentation was designed to significantly improve vaccination practices for poultry producers while maintaining reliable virus protection.

Boehringer says this dispensing form reduces the risk of stock solution contamination and, when compared to glass vials, the small blister packs make vaccine management safer for operators, take up less room in the fridge and reduce packaging waste by 90%.

HatchPak IB H120 NeO will be available shortly in packs of 10 tablets of 1000 doses or 10 tablets of 2000 doses.

Callum Blair, Boehringer Ingelheim Avian and Swine Brand Manager, said: "The addition of HatchPak IB H120 NeO to our NeO product portfolio is evidence of our continued investment in the poultry sector."

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.